Keywords: Mylan, Bioniche Pharma, Injectables, Biologics
Mylan pays $550 million for Ireland’s Bioniche to gain access to US injectables market
Article | 15 July 2010
US generic drugmaker Mylan says it will acquire privately-held Ireland based Bioniche Pharma for $550 million in cash. Bioniche will provide ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
